We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. Our therapeutic areas of focus include Infectious Diseases, HIV, Oncology, and Immunology.
We aim to positively impact the health of 2.5 billion people over the next 10 years. Our bold ambitions for patients are reflected in new commitments to growth and a step-change in performance.